01—Abstract
Summary
Summary of the 8-K filed November 18, 2024. Cited figures are marked; the original filing is the authoritative source.
ADM reported third-quarter 2024 results that were largely in line with preliminary figures released earlier, and filed its Q3 10-Q alongside restated financial statements for fiscal 2023 and the first two quarters of 2024.
GAAP results were sharply weaker: Q3 earnings before income taxes fell 90% year over year to $108 milliona, and GAAP diluted EPS was $0.04, versus $1.52 a year earlier. The decline was driven mainly by a non-cash $461 million impairment on ADM's Wilmar equity investment, which was deemed other-than-temporary given the decline in its Singapore Exchange trading price. Excluding specified items, adjusted EPS was $1.09 (down 33%) and total segment operating profit was $1,037 million (down 28%).
The core drag came from Ag Services & Oilseeds, where segment profit fell 43% on lower South American origination margins, weaker Refined Products & Other margins (driven by imported used cooking oil and biodiesel pressure), and mark-to-market timing swings. Carbohydrate Solutions was roughly flat, with Starches & Sweeteners up 13% offset by a loss at Vantage Corn Processors, while Nutrition fell 19% on Decatur East downtime and weaker texturants pricing. Management affirmed full-year 2024 adjusted EPS guidance of $4.50 to $5.00b, implying a sharp fourth-quarter step-up from the year-to-date run-rate of $3.61.
The company said it expects softer market conditions into 2025, and it flagged that further Wilmar-related charges are possible. It also noted that Q3 benefited from roughly $96 millionc of insurance settlements related to the 2023 Decatur incidents, which are non-recurring in nature.
The restatement involved intersegment transactions and, per the company, had no effect on consolidated balance sheet, earnings, or cash flows. Investors should still weigh the governance and internal-control remediation that the restatement signals, along with the company's continued share repurchases ($2.3 billiond year-to-date) and rising short-term debt ($1.7 billion versus $116 million a year earlier).
02—Key points
Key Highlights
- GAAP diluted EPS of $0.04 versus $1.52 in Q3 2023; GAAP net earnings of $18 million, reflecting a $461 million non-cash Wilmar impairment charge.
- Adjusted EPS of $1.09 (down 33% YoY) and total segment operating profit of $1,037 million (down 28%), with Ag Services & Oilseeds down 43% to $480 million.
- Year-to-date adjusted EPS of $3.61 (down 36%); full-year 2024 adjusted EPS guidance affirmed at $4.50 to $5.00, implying a substantial Q4 ramp.
- Restatement of FY2023 10-K and Q1/Q2 2024 10-Qs tied to intersegment transactions; company states no impact on consolidated earnings, balance sheet, or cash flows, but internal-control enhancements are ongoing.
- Q3 included roughly $96 million of partial insurance settlements for the Decatur East and West incidents, flattering segment results and not expected to recur.
- Operating cash flow of $2,468 million YTD, but cash flow before working capital fell to $2,341 million from $3,804 million a year earlier.
- Balance sheet shows short-term debt rising to $1,733 million from $116 million, while cash fell to $784 million from $1,498 million, alongside $2.3 billion of YTD share repurchases.
03—Questions
Frequently Asked Questions
Why did GAAP earnings fall so sharply in Q3 2024?
The largest factor was a non-cash $461 million impairment on ADM's equity investment in Wilmar, which ADM concluded was other-than-temporarily impaired after the Singapore Exchange trading price declined. Specified items totaled about $504 million pre-tax, or roughly $1.03 per share, for the quarter. Excluding these items, adjusted EPS was $1.09.
What was behind the weakness in core operating segments?
Ag Services & Oilseeds fell 43% on lower South American origination margins, higher logistics costs tied to take-or-pay contracts, and weaker Refined Products & Other results, which were hit by higher used cooking oil imports and added pretreatment capacity. Nutrition declined 19% on Decatur East downtime and lower texturants margins. Carbohydrate Solutions was largely stable, with Starches & Sweeteners up 13% offsetting a loss at Vantage Corn Processors.
Is the 2024 guidance achievable given the year-to-date results?
The guidance of $4.50 to $5.00 adjusted EPS requires a meaningful Q4 improvement, since YTD adjusted EPS is $3.61, implying roughly $0.89 to $1.39 in Q4. Management expects the fourth quarter to show lower year-over-year segment profit in AS&O and roughly flat results in Carbohydrate Solutions, with Nutrition improving on the prior year but below Q3 levels. Management also warned of softer market conditions into 2025, so investors should monitor whether the implied Q4 ramp materializes.
Does the restatement affect ADM's reported financial results?
According to ADM, no. The restatement corrected intersegment transactions, so consolidated balance sheet, earnings, and cash flow figures were unchanged. Segment-level figures for 2023 and the first half of 2024 were adjusted, however, and ADM says it is continuing to strengthen internal controls over financial reporting.
What are the risks of further write-downs related to Wilmar?
ADM said it continues to evaluate trends in the Wilmar share price and that additional charges could follow if the valuation declines further. Because Wilmar is an equity investment carried at trading value, its carrying amount is sensitive to market moves. ADM also noted that it cannot predict the timing or size of impairments, restructuring, or other items with reasonable certainty, so future GAAP results could differ materially from adjusted figures.
04—Continue